Manas Polymers (MPEL)
CyclicalScore breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹48 |
| Market Cap | ₹42.77 Cr |
| P/E Ratio | 9.97 |
| ROCE | 32.46% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| Promoter Holding | 62.62% |
| 52-Week Range | ₹22.35 — ₹72.8 |
| Sector | Industrial Products |
Strengths
- Attractive trailing P/E of 9.97 with a market cap of ₹43 Cr
- Strong ROCE of 32.46% indicates efficient use of capital
- Latest quarter profitable: ₹4 Cr net profit on ₹22 Cr sales
- Promoter holding of 62.62% aligns management with minority shareholders
Concerns
- Zero sales growth and zero profit growth
- Piotroski F-score of 3/9 signals weak financial health
- No dividend and insufficient balance-sheet data (no book value, debt/equity)
- Stock has fallen significantly from 52-week high of ₹72.80 to ₹48
AI Analysis
At ₹48, Manas Polymers is a micro-cap with a market cap of just ₹43 crore. The first thing that catches my eye is the P/E of 9.97 and a ROCE of 32.46%. That is an attractive combination on paper. But Graham taught me that a single ratio is never enough. The same data set shows zero sales growth, zero profit growth, no dividend, and a Piotroski F-score of only 3/9. That is not the profile of a high-quality compounder. The latest quarter shows sales of ₹22 crore and net profit of ₹4 crore, which is a healthy margin, but one quarter tells me little about the durability of the business. I also do not have book value, return on equity, or debt-to-equity figures; without those, I cannot measure the true financial strength of the company. Industrial plastics is a competitive, cost-sensitive field, and these numbers do not reveal any unique moat or pricing power. On the positive side, promoter holding is 62.62%, so the owners have skin in the game. The stock is 34% below its 52-week high of ₹72.80 and still about 37% above its low, which suggests a volatile, uncertain market. Value investing demands both a decent business and a margin of safety. Manas may have a decent capital efficiency number, but the missing balance-sheet data, weak F-score, and absence of growth make me uncomfortable. I would watch this micro-cap patiently, but I would not buy it merely because it looks statistically cheap. I need evidence of consistent earnings, a clean balance sheet, and a reason revenue growth will resume before I commit capital.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer